Lecuelle, J.; Boidot, R.; Mananet, H.; Derangère, V.; Albuisson, J.; Goussot, V.; Arnould, L.; Tharin, Z.; Ray Coquard, I.; Ghiringhelli, F.;
et al. TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer. Cancers 2021, 13, 4394.
https://doi.org/10.3390/cancers13174394
AMA Style
Lecuelle J, Boidot R, Mananet H, Derangère V, Albuisson J, Goussot V, Arnould L, Tharin Z, Ray Coquard I, Ghiringhelli F,
et al. TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer. Cancers. 2021; 13(17):4394.
https://doi.org/10.3390/cancers13174394
Chicago/Turabian Style
Lecuelle, Julie, Romain Boidot, Hugo Mananet, Valentin Derangère, Juliette Albuisson, Vincent Goussot, Laurent Arnould, Zoé Tharin, Isabelle Ray Coquard, François Ghiringhelli,
and et al. 2021. "TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer" Cancers 13, no. 17: 4394.
https://doi.org/10.3390/cancers13174394
APA Style
Lecuelle, J., Boidot, R., Mananet, H., Derangère, V., Albuisson, J., Goussot, V., Arnould, L., Tharin, Z., Ray Coquard, I., Ghiringhelli, F., Truntzer, C., & Fumet, J. -D.
(2021). TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer. Cancers, 13(17), 4394.
https://doi.org/10.3390/cancers13174394